glp 1 receptor agonists contraindications Incretins: How we got here, where we're at and what is coming next GLP-1 Receptor Agonists and vision
Description
Trivedi, A
doi: 10.1093/humrep/dey256 2 ChangSDunaifA
( 10.1172/JCI7456) [DOI] [PMC free article] [PubMed] [Google Scholar] Nikolaidis LA Elahi D Hentosz T Doverspike A Huerbin R Zourelias L Stolarski C Shen YT & Shannon RP
It leads us to really think about the promise of these types of new medications for Alzheimers disease or other types of dementia, Rebecca Edelmayer, senior director of scientific engagement for the Alzheimers Association, says to USA Today s Ken Alltucker
Unimolecular, multi-receptor agonists have emerged to meet this growing need
